This study investigates the combined treatment of Biyuan Tongqiao Granules and Triamcinolone Acetonide Nasal Spray for chronic rhinosinusitis (CRS), utilizing a randomized controlled trial that included 9 studies with 1,145 participants.
The results showed that the combination therapy significantly improved the effective rate of treatment and decreased the nasal mucociliary transport time compared to the spray alone, with no notable difference in adverse effects between the treatment groups.
Additionally, the analysis revealed that while the combination therapy was more expensive, it provided a better cost-effectiveness in improving treatment outcomes for CRS, influencing factors such as treatment duration and drug pricing.